Dongsheng Pharmaceutical International Co logo

DNGH - Dongsheng Pharmaceutical International Co Share Price

$0.01 0.0  0.0%

Last Trade -

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £122k
Enterprise Value £7.62k
Revenue £18.3m
Position in Universe th / 6715
Bullish
Bearish
Unlock DNGH Revenue
Momentum
Relative Strength (%)
1m -3.19%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2005 2006 2007 2008 2009 2010 2011E 2012E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 20.5
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 March 2011, DongshengPharmaceutical Intl Co Ltd revenues increased from $2.4M to$9.8M. Net income decreased 59% to $557K. Revenues reflectan increase in demand for the Company's products andservices due to favorable market conditions. Net income wasoffset by Recovery of doubtful accounts decrease from $1M(income) to $0K, Selling and distribution expenses increasefrom $26K to $545K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

DNGH Revenue Unlock DNGH Revenue

Net Income

DNGH Net Income Unlock DNGH Revenue

Normalised EPS

DNGH Normalised EPS Unlock DNGH Revenue

PE Ratio Range

DNGH PE Ratio Range Unlock DNGH Revenue

Dividend Yield Range

DNGH Dividend Yield Range Unlock DNGH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
DNGH EPS Forecasts Unlock DNGH Revenue
Profile Summary

Dongsheng Pharmaceutical International Co., Ltd. (Dongsheng), formerly Indestructible I, Inc., is a pharmaceutical wholesaler in the People's Republic of China, which specializes in the wholesale and distribution of high-quality, high-margin and high-demand drugs, mainly to secondary and third- tier regional drug wholesalers in China. Its major suppliers are pharmaceutical manufacturers. Its main pharmaceutical products primarily cover the therapeutic areas, such as Parkinson's disease, cardiovascular, immunology and infectious diseases. The Company's core operational subsidiary is Sichuan Xintai Pharmaceutical Co., Ltd. (Xintai). The Company's products include Ganglioside, Edaravone, Salvianolate, Sulbenicillin Injection and Imipenem/cilastatin Injection. On March 25, 2010, the Company acquired Dynamic Bhorizon Limited (DBL).

Directors
Last Annual June 30th, 2010
Last Interim March 31st, 2011
Incorporated March 25, 2008
Public Since July 17, 2009
No. of Shareholders: 117
No. of Employees: 69
Sector Consumer Defensives
Industry Food & Drug Retailing
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 17,000,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
DNGH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for DNGH
Upcoming Events for DNGH
Frequently Asked Questions for Dongsheng Pharmaceutical International Co
What is the Dongsheng Pharmaceutical International Co share price?

As of , shares in Dongsheng Pharmaceutical International Co are trading at $0.01, giving the company a market capitalisation of £122k. This share price information is delayed by 15 minutes.

How has the Dongsheng Pharmaceutical International Co share price performed this year?

Shares in Dongsheng Pharmaceutical International Co are currently trading at $0.01 and the price has moved by 9.90k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Dongsheng Pharmaceutical International Co price has moved by 7.53k% over the past year.

What are the analyst and broker recommendations for Dongsheng Pharmaceutical International Co?

There are no analysts currently covering Dongsheng Pharmaceutical International Co.

When will Dongsheng Pharmaceutical International Co next release its financial results?

Dongsheng Pharmaceutical International Co is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2012-03-31
What is the Dongsheng Pharmaceutical International Co dividend yield?

Dongsheng Pharmaceutical International Co does not currently pay a dividend.

Does Dongsheng Pharmaceutical International Co pay a dividend?

Dongsheng Pharmaceutical International Co does not currently pay a dividend.

When does Dongsheng Pharmaceutical International Co next pay dividends?

Dongsheng Pharmaceutical International Co does not currently pay a dividend.

How do I buy Dongsheng Pharmaceutical International Co shares?

To buy shares in Dongsheng Pharmaceutical International Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Dongsheng Pharmaceutical International Co?

Shares in Dongsheng Pharmaceutical International Co are currently trading at $0.01, giving the company a market capitalisation of £122k.

Where are Dongsheng Pharmaceutical International Co shares listed? Where are Dongsheng Pharmaceutical International Co shares listed?

Here are the trading details for Dongsheng Pharmaceutical International Co:

Country of listing: United States
Exchange: PNK
Ticker Symbol: DNGH
What kind of share is Dongsheng Pharmaceutical International Co?

We were not able to load our ranking data for Dongsheng Pharmaceutical International Co

Is there a Dongsheng Pharmaceutical International Co share price forecast 2021?

We were not able to load any forecast data for Dongsheng Pharmaceutical International Co.

How can I tell whether the Dongsheng Pharmaceutical International Co share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dongsheng Pharmaceutical International Co. Over the past six months, the relative strength of its shares against the market has been 0.116k%. At the current price of $0.01, shares in Dongsheng Pharmaceutical International Co are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Dongsheng Pharmaceutical International Co PE Ratio?

The Dongsheng Pharmaceutical International Co PE ratio based on its reported earnings over the past 12 months is 0.09. The shares are currently trading at $0.01.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Dongsheng Pharmaceutical International Co?

We were unable to find the directors for Dongsheng Pharmaceutical International Co.

Who are the major shareholders of Dongsheng Pharmaceutical International Co?

Here are the top five shareholders of Dongsheng Pharmaceutical International Co based on the size of their shareholding:

Similar to DNGH
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.